NPAS

NPAS
Name	NPAS

NPAS is a biological system implicated in regulatory processes across species, integrating environmental cues and internal signals to influence behavior, physiology, and development. It interacts with numerous molecular pathways and cellular networks, contributing to homeostasis, adaptive responses, and disease states. Research on NPAS spans molecular biology, neuroscience, endocrinology, and clinical medicine, engaging a wide range of laboratories, institutes, and consortia.

Overview

NPAS operates at the intersection of signaling cascades, transcriptional regulation, and cellular physiology, coordinating responses that involve entities such as National Institutes of Health, Howard Hughes Medical Institute, Max Planck Society, Cold Spring Harbor Laboratory, Francis Crick Institute, Salk Institute, Broad Institute, European Molecular Biology Laboratory, Wellcome Trust Sanger Institute, Johns Hopkins University School of Medicine, Harvard Medical School, Massachusetts Institute of Technology, Stanford University School of Medicine, University of California, San Francisco, Rockefeller University, Yale School of Medicine, University of Cambridge, University of Oxford, Karolinska Institutet, University of Tokyo, Imperial College London, McGill University, University of Toronto, Peking University, Tsinghua University, Seoul National University, University of Melbourne, University of Sydney, ETH Zurich, University of Zurich, University of California, Los Angeles, Columbia University Irving Medical Center, Mayo Clinic, Cleveland Clinic, Vanderbilt University Medical Center, Duke University School of Medicine, University of Pennsylvania Perelman School of Medicine, Weill Cornell Medicine, Utrecht University, University of Edinburgh, King's College London, Addenbrooke's Hospital, Beth Israel Deaconess Medical Center, Children's Hospital of Philadelphia, St Jude Children's Research Hospital, Memorial Sloan Kettering Cancer Center, and Dana-Farber Cancer Institute in generating key data and resources. Works published in journals like Nature, Science, Cell, The Lancet, New England Journal of Medicine, Proceedings of the National Academy of Sciences, Nature Communications, Nature Neuroscience, Journal of Clinical Investigation, Neuron, EMBO Journal, PNAS Nexus, PLoS Biology, eLife, Molecular Cell, Journal of Biological Chemistry, Genome Research, Nature Genetics, Nature Medicine, Clinical Infectious Diseases, Gut, Blood, Cancer Cell, Cell Reports, Frontiers in Neuroscience, Brain, JAMA, BMJ have shaped understanding.

History

The conceptualization and experimental elucidation of NPAS emerged through cumulative discoveries by investigators affiliated with institutions such as University of Pennsylvania, Princeton University, California Institute of Technology, University of Chicago, Cornell University, University of California, Berkeley, Baylor College of Medicine, Wake Forest School of Medicine, Emory University School of Medicine, University College London, Institut Pasteur, CEA Saclay, Karolinska Institutet, Max Planck Institute for Brain Research, and Riken. Early biochemical and genetic work built on foundational studies by figures associated with Nobel Prize in Physiology or Medicine laureates and laboratories recognized for advances in molecular genetics, developmental biology, and neurobiology. Landmark conferences at venues including Cold Spring Harbor Laboratory meetings, Gordon Research Conferences, and Keystone Symposia accelerated cross-disciplinary collaboration. Key technical milestones incorporated methods pioneered by teams at Salk Institute and Broad Institute such as high-throughput sequencing, CRISPR-based perturbation, single-cell transcriptomics, chromatin immunoprecipitation, and in vivo imaging used in model systems maintained at Jackson Laboratory, European Molecular Biology Laboratory facilities, and major core facilities at Francis Crick Institute.

Structure and Function

At molecular and cellular levels NPAS engages with transcription factors, co-regulators, chromatin modifiers, signaling receptors, second messenger systems, metabolic enzymes, ion channels, and cytoskeletal elements characterized in studies at Nature Reviews Molecular Cell Biology, Cell Metabolism, and specialized labs at Harvard Medical School and Stanford University. Its spatial organization spans subcellular compartments, neural circuits mapped in model organisms housed at Max Planck Institute for Biological Intelligence and Salk Institute, and organ systems investigated at clinical centers such as Mayo Clinic and Cleveland Clinic. Interaction partners include proteins and complexes frequently studied by groups at European Molecular Biology Laboratory, Weill Cornell Medicine, and University of California, San Diego. Functional roles encompass modulation of circadian-like timing, stress responses, developmental patterning, synaptic plasticity, metabolic regulation, immune modulation, and vascular dynamics — topics also central to research at Johns Hopkins University School of Medicine, University of Oxford, University of Cambridge, Imperial College London, Karolinska Institutet, University of Toronto, and Peking University.

Clinical Significance and Pathology

Dysregulation of NPAS pathways is linked to a spectrum of clinical phenotypes investigated at referral centers including Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Brigham and Women's Hospital, Mount Sinai Hospital, Johns Hopkins Hospital, UCLA Medical Center, UCSF Medical Center, Toronto General Hospital, Guy's and St Thomas' NHS Foundation Trust, Addenbrooke's Hospital, and Royal Free Hospital. Associations have been reported with neurodevelopmental disorders, neurodegenerative diseases, psychiatric conditions, metabolic syndromes, inflammatory disorders, cardiovascular pathology, oncogenesis, and rare inherited syndromes cataloged in databases curated by ClinVar, OMIM, Human Genome Organisation, and consortia such as International Cancer Genome Consortium and The Cancer Genome Atlas. Clinical studies and trials registered with organizations like National Institutes of Health and conducted at centers including Dana-Farber Cancer Institute, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Vanderbilt University Medical Center, Duke University School of Medicine, Stanford University School of Medicine, and University of California, San Francisco explore therapeutic modulation.

Diagnosis and Testing

Diagnostic evaluation of NPAS-related dysfunction leverages genomic sequencing platforms developed at Broad Institute, Wellcome Trust Sanger Institute, Illumina, and laboratory networks at Massachusetts General Hospital, Mayo Clinic, Stanford Clinical Genomics Service, University College London Hospitals, Cambridge University Hospitals NHS Foundation Trust, Karolinska University Hospital, Riken Center for Integrative Medical Sciences, Peking University Third Hospital, Seoul National University Hospital, National University Hospital (Singapore), and reference laboratories supporting ClinVar and HGMD submissions. Assays include targeted gene panels, exome sequencing, whole-genome sequencing, transcriptomic profiling, proteomics, metabolomics, immunohistochemistry, functional cellular assays, and neuroimaging studies available at centers such as UCSF Medical Center, Massachusetts General Hospital, Johns Hopkins Hospital, and Mayo Clinic. Bioinformatic pipelines and variant interpretation frameworks have been advanced by groups at Broad Institute, European Bioinformatics Institute, Wellcome Trust Sanger Institute, Stanford Center for Genomics and Personalized Medicine, and University of California, Santa Cruz.

Treatment and Management

Management strategies for NPAS-associated conditions combine targeted molecular therapies, pharmacological modulation, gene therapies, supportive care, rehabilitation, and lifestyle interventions investigated in clinical trials at National Institutes of Health Clinical Center, Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Johns Hopkins Hospital, UCLA Medical Center, Vanderbilt University Medical Center, Duke University School of Medicine, Stanford University School of Medicine, University of Pennsylvania Perelman School of Medicine, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Great Ormond Street Hospital, and collaborative networks like European Reference Networks. Emerging approaches draw on gene editing platforms refined at Broad Institute, viral vector delivery systems developed in industry and academic labs, small-molecule screening from consortia tied to Wellcome Trust, and repurposed agents evaluated in trials registered by National Institutes of Health. Multidisciplinary care teams at tertiary centers coordinate genetic counseling, symptomatic therapies, and monitoring protocols aligned with best practices promulgated by professional bodies and specialty societies.

Category:Biology